European Union - English - EMA (European Medicines Agency)

biolitec pharma ltd - temoporfin - head and neck neoplasms; carcinoma, squamous cell - antineoplastic agents - foscan is indicated for the palliative treatment of patients with advanced head and neck squamous cell carcinoma failing prior therapies and unsuitable for radiotherapy, surgery or systemic chemotherapy.

Israel - English - Ministry of Health

einat medical agencies (1997) ltd - temoporfin 4 mg/ml - solution for injection - temoporfin - foscan is indicated for the palliative treatment of patients with advanced head and neck squamous cell carcinoma failing prior therapies and unsuitable for radiotherapy, surgery or systemic chemotherapy.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

biolitec pharma ltd - temoporfin - solution for injection - 4mg/1ml